Latest Content

Navigating the Holidays When Cancer Never Quite Leaves

December 16th 2025, 6:00pm

By Linda Cohen

Article

Living with chronic cancer means navigating the holidays with extra caution — but also with deeper gratitude for every moment I’m able to show up.

SHARON Trial Offers a Potential Approach for Advanced Pancreatic Cancer

December 16th 2025, 5:03pm

By Ryan Scott

Article

A potential new approach to treating advanced pancreatic cancer has shown benefit for patients, according to Dr. Eileen M. O'Reilly.

FDA Grants Fast Track Status to Muzastotug for Some Colorectal Cancers

December 16th 2025, 4:00pm

By Spencer Feldman

Article

The FDA granted fast track status to muzastotug plus Keytruda for adults with microsatellite stable metastatic colorectal cancer without liver metastases.

Bleximenib/Venclexta Treatment Combo is Safe in Early AML Trial

December 16th 2025, 2:00pm

By Dr. Jenny O’Nions

Video

Bleximenib and Venclexta treatment were well tolerated in a phase 1b trial for relapsed/refractory acute myeloid leukemia with mostly low-grade side effects.

Cancer in the Rearview Mirror

December 15th 2025, 10:00pm

By John Smelcer, PhD, CAGS

Article

It’s been two-and-a-half years since I “rang the bell” on the Oncology ward, signaling that I had ended my chemotherapy treatment.

Facing Lung Cancer Together: A Patient and Care Partner Share Their Journey

December 15th 2025, 9:00pm

By Ryan Scott

Article

Wendy and Larry Brooks share their journey with small cell lung cancer, emphasizing the importance of screening, as well as advocacy for patients and caregivers.

FDA Approves Enhertu Plus Perjeta in Advanced HER2+ Breast Cancer

December 15th 2025, 7:15pm

By Alex Biese

Article

The FDA has approved Enhertu and Perjeta for the first-line treatment of unresectable or metastatic HER2-positive breast cancer.

Accepting That You Are Changed by Cancer

December 15th 2025, 6:00pm

By Debbie Legault

Article

I usually write about my daughter’s cancer, but my friend’s stage 4 breast cancer journey showed me the limits of strength and the need for help.

FDA Grants Breakthrough Designation to INCA-33989 in Essential Thrombocythemia

December 15th 2025, 5:00pm

By Alex Biese

Article

The FDA has granted breakthrough therapy designation to INCA033989 for some patients with essential thrombocythemia.

Loqtorzi Nearly Doubles Long-Term Survival in Nasopharyngeal Cancer

December 15th 2025, 4:00pm

By Spencer Feldman

Article

Six-year phase 3 follow-up showed adding Loqtorzi to chemotherapy nearly doubled survival for recurrent or metastatic nasopharyngeal cancer.

Spending the Holidays in Cancer Treatment

December 15th 2025, 2:00pm

By Sue McCarthy

Article

As I reflect on my lung cancer journey, I look back to the 2018 holiday season, feeling comfortable and at peace.

Light the Night and Survivorship: The Importance of Remembrance

December 14th 2025, 7:00pm

By Kim Johnson

Article

I attended this year’s Light the Night walk in remembrance of my sister, reflecting on her 11-year battle and enduring identity as a cancer survivor.

Stage 3 Prostate Cancer: A Guide to Diagnosis, Treatment, and Next Steps

December 14th 2025, 3:00pm

By Gina Mauro

Article

Newly diagnosed with stage 3 prostate adenocarcinoma? Understand your diagnosis and explore multimodality treatment options for an informed cancer journey.

Bladder Adenocarcinoma: An Overview for the Newly Diagnosed

December 13th 2025, 7:00pm

By Alex Biese

Article

This guide features information from diagnosis to treatment of adenocarcinoma of the bladder.

Rising Lung Cancer Rates Targets Asian Women Nonsmokers in California

December 13th 2025, 3:00pm

By Dr. Jeffrey B. Velotta

Video

Asian women who do not smoke in Northern California face rising lung cancer rates which are often diagnosed late due to current screening gaps.